The missing link biomarker in cardiac testing

Welcome to CardiNor
– developing the missing link biomarker test for cardiovascular disease

CardiNor AS is a Norwegian biotech company recently established to handle the commercialization of Secretoneurin (SN), a new biomarker for cardiovascular disease (CVD).

Facts and figures

US cost on cardiovascular disease 3500 USD/sec.
One heart attac in US every 43 sec.

Latest news from CardiNor

CardiNor AS and its partners Bioventix Ltd, Kaivogen Oy and Akershus University hospital have been granted Eurostars funding of the project: Secretoneurin, a breakthrough blood biomarker for heart disease and Sudden Cardiac Arrest risk. The total funding by EU is € 631,000. The Eurostars project will support the following important milestones for the company: Development and optimization of a simple test for measuring SN in the blood – Clinical validation using a very comprehensive patient material, this will also support and facilitate future CE marking – Optimization  of assay production that will enable rapid commercialization. Read more

Contact Us

Send us an email and we'll get back to you, asap.